UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
May 2, 2024
Accession Number:
0001493152-24-017312
Submission Type:
POS AM
CIK:
0001460702
Company Name:
Qualigen Therapeutics, Inc.
File Number:
333-269088